Zydus Announces Positive Topline Results from Completed EVIDENCES-X Phase II(b) Clinical Trial of Saroglitazar Mg in MASH.
Ahmedabad, India, 31st August 2026 Zydus, a leading innovation-led global lifesciences company, today announced positive topline results from its completed...